Latest news
Loading news…
Psyadon Pharmaceuticals is dedicated to the discovery and development of new treatments for serious psychiatric and neurological diseases.
Psyadon Pharmaceuticals was acquired by Emalex Biosciences in 2018.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Germantown, Maryland, United States
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Psyadon Pharmaceuticals
Loading news…
FAQs about Psyadon Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.